Literature DB >> 11336440

Quantitative analysis of microvascular alterations in traumatic brain injury by endothelial barrier antigen immunohistochemistry.

B Lin1, M D Ginsberg, W Zhao, O F Alonso, L Belayev, R Busto.   

Abstract

Endothelial barrier antigen (EBA) is a protein triplet located in the plasma membrane of microvascular endothelium and selectively expressed in the normal nervous system. In this study, microvascular alterations following traumatic brain injury were studied using EBA immunohistochemistry. Anesthetized, physiologically regulated, normothermic Sprague-Dawley rats received moderate (1.5-2.0 atm) parieto-occipital parasagittal fluid-percussion traumatic brain injury (TBI). Control rats were subjected to similar anesthesia and physiological monitoring. Seven days after operative procedures, brains were perfusion-fixed, and coronal sections were reacted for EBA immunohistochemistry using a monoclonal antibody to rat EBA. Selected sections were reacted for isolectin B4 histochemistry. Computerized image analysis was used to compute numbers of EBA-immunopositive vascular profiles and mean vascular profile areas. In control brains, virtually all brain microvessels were clearly and positively immunostained, and antibody binding was specific for blood vessels. In rats with TBI, EBA immunoreactivity was greatly reduced in the zone of cortical contusion. Within the core contusion, fractional areas occupied by vascular profiles were markedly reduced (on average, by 57%), vascular profile counts were diminished, and lectin histochemistry revealed a robust inflammatory response with abundant macrophages. Taken together, these findings were thought to indicate frank microvascular destruction. At adjacent peri-contusional sites, the intensity of EBA immunostaining was also diminished; and vascular profile counts were reduced at adjacent cortical sites and homologous contralateral sites. The latter findings were interpreted as sublethal microvascular alterations possibly related to cerebral edema. The present results confirm that EBA is a specific immunohistochemical marker of normal central nervous system microvessels; that it is suitable for use in formaldehyde-fixed material; and that it is useful in quantitatively assessing microvascular alterations observed at contusional, peri-contusional and more remote sites following traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336440     DOI: 10.1089/089771501750170958

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  18 in total

Review 1.  Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury.

Authors:  Roshini Prakash; S Thomas Carmichael
Journal:  Curr Opin Neurol       Date:  2015-12       Impact factor: 5.710

2.  Postinjury treatment with rolipram increases hemorrhage after traumatic brain injury.

Authors:  C M Atkins; Y Kang; C Furones; J S Truettner; O F Alonso; W D Dietrich
Journal:  J Neurosci Res       Date:  2012-04-26       Impact factor: 4.164

3.  Erythropoietin mediates neurobehavioral recovery and neurovascular remodeling following traumatic brain injury in rats by increasing expression of vascular endothelial growth factor.

Authors:  Ye Xiong; Yanlu Zhang; Asim Mahmood; Yuling Meng; Changsheng Qu; Michael Chopp
Journal:  Transl Stroke Res       Date:  2011-12-01       Impact factor: 6.829

4.  Cerebral blood volume alterations in the perilesional areas in the rat brain after traumatic brain injury--comparison with behavioral outcome.

Authors:  Riikka Immonen; Taneli Heikkinen; Leena Tähtivaara; Antti Nurmi; Taina-Kaisa Stenius; Jukka Puoliväli; Tinka Tuinstra; Amie L Phinney; Bernard Van Vliet; Juha Yrjänheikki; Olli Gröhn
Journal:  J Cereb Blood Flow Metab       Date:  2010-02-10       Impact factor: 6.200

5.  Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood-brain barrier during extravasation and brain invasion.

Authors:  Kate M Lewis; Elizabeth Harford-Wright; Robert Vink; Alan J Nimmo; Mounir N Ghabriel
Journal:  Clin Exp Metastasis       Date:  2012-05-19       Impact factor: 5.150

6.  Effects of polycaprolactone-based scaffolds on the blood-brain barrier and cerebral inflammation.

Authors:  Vincent Diong Weng Nga; Jing Lim; David Kim Seng Choy; Mya Aye Nyein; Jia Lu; Ning Chou; Tseng Tsai Yeo; Swee-Hin Teoh
Journal:  Tissue Eng Part A       Date:  2015-01-22       Impact factor: 3.845

7.  Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury.

Authors:  Yanlu Zhang; Michael Chopp; Zheng Gang Zhang; Mark Katakowski; Hongqi Xin; Changsheng Qu; Meser Ali; Asim Mahmood; Ye Xiong
Journal:  Neurochem Int       Date:  2016-08-15       Impact factor: 3.921

8.  Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression.

Authors:  Bruno Saubaméa; Véronique Cochois-Guégan; Salvatore Cisternino; Jean-Michel Scherrmann
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-27       Impact factor: 6.200

9.  Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion.

Authors:  J Marc Simard; Michael Kilbourne; Orest Tsymbalyuk; Cigdem Tosun; John Caridi; Svetlana Ivanova; Kaspar Keledjian; Grant Bochicchio; Volodymyr Gerzanich
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

10.  Cortical spreading depression activates and upregulates MMP-9.

Authors:  Yasemin Gursoy-Ozdemir; Jianhua Qiu; Norihiro Matsuoka; Hayrunnisa Bolay; Daniela Bermpohl; Hongwei Jin; Xiaoying Wang; Gary A Rosenberg; Eng H Lo; Michael A Moskowitz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.